Gregory Albers
Dr. Gregory W. Albers is the director of the Stanford Stroke Center, a position he has held since co-founding the center in 1992. A world leader in stroke research and treatment, the Stanford Stroke Center has pioneered major advances in medical therapies and consistently ranks among the most prolific research groups in the United States.
Dr. Albers’ primary research focus is the diagnosis, management, and prevention of ischemic stroke. Dr. Albers and his team use advanced imaging technology to expand the treatment window for ischemic stroke, thereby improving patient health and quality of life outcomes.
Dr. Albers conducts clinical studies of treatments for acute stroke, including both thrombolytic strategies (which dissolve blood clots) and neuroprotective strategies (which seek to limit neuronal damage). He also investigates new antithrombotic strategies for stroke prevention.
Dr. Albers was instrumental in the development of medical software, RAPID, that interprets patient brain scans and helps clinicians decide on appropriate treatments for ischemic stroke.
A prolific and distinguished researcher, Dr. Albers has authored more than 750 articles on topics related to cerebrovascular disease in peer-reviewed journals.
Abstracts this author is presenting: